EU Extends Review of Teva Pharmaceutical Industries Limited Bid for Barr Pharmaceuticals, Inc.

December 2, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRUSSELS, Dec 2 (Reuters) - The European Commission on Tuesday extended its review of Israeli drugmaker Teva Pharmaceutical's bid to acquire U.S. biopharmaceutical and generic drugs marketer Barr Pharmaceuticals Inc.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe